Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Kaping

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Progress in Neurobiology|December 24, 2023
Phase of neural oscillations as a reference frame for attention-based routing in visual cortexEhsan Aboutorabi, Sonia Baloni Ray, Daniel Kaping, et al.
Current Medicinal Chemistry|May 18, 2018
A Systematic Review on Donepezil-based Derivatives as Potential Cholinesterase Inhibitors for Alzheimer's DiseaseJan Korabecny, Katarina Spilovska, Eva Mezeiova, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 11, 2019
Tuberous Sclerosis (tsc2+/-) Model Eker Rats Reveals Extensive Neuronal Loss with Microglial Invasion and Vascular Remodeling Related to Brain NeoplasiaViera Kútna, Libor Uttl, Robert Waltereit, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 6, 2015
Sharp Wave Ripples during Visual Exploration in the Primate HippocampusTimothy K Leonard, Jonathan M Mikkila, Emad N Eskandar, et al.
Journal of Neurodevelopmental Disorders|April 17, 2021
mTOR inhibitor improves autistic-like behaviors related to Tsc2 haploinsufficiency but not following developmental status epilepticusTomas Petrasek, Iveta Vojtechova, Ondrej Klovrza, et al.
Molecules (Basel, Switzerland)|June 17, 2017
Novel Tacrine-Scutellarin Hybrids as Multipotent Anti-Alzheimer's Agents: Design, Synthesis and Biological EvaluationKatarina Spilovska, Jan Korabecny, Vendula Sepsova, et al.
Molecules (Basel, Switzerland)|August 10, 2017
Development of 2-Methoxyhuprine as Novel Lead for Alzheimer's Disease TherapyEva Mezeiova, Jan Korabecny, Vendula Sepsova, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Progress in Neurobiology|December 24, 2023
Phase of neural oscillations as a reference frame for attention-based routing in visual cortexEhsan Aboutorabi, Sonia Baloni Ray, Daniel Kaping, et al.
Current Medicinal Chemistry|May 18, 2018
A Systematic Review on Donepezil-based Derivatives as Potential Cholinesterase Inhibitors for Alzheimer's DiseaseJan Korabecny, Katarina Spilovska, Eva Mezeiova, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 11, 2019
Tuberous Sclerosis (tsc2+/-) Model Eker Rats Reveals Extensive Neuronal Loss with Microglial Invasion and Vascular Remodeling Related to Brain NeoplasiaViera Kútna, Libor Uttl, Robert Waltereit, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 6, 2015
Sharp Wave Ripples during Visual Exploration in the Primate HippocampusTimothy K Leonard, Jonathan M Mikkila, Emad N Eskandar, et al.
Journal of Neurodevelopmental Disorders|April 17, 2021
mTOR inhibitor improves autistic-like behaviors related to Tsc2 haploinsufficiency but not following developmental status epilepticusTomas Petrasek, Iveta Vojtechova, Ondrej Klovrza, et al.
Molecules (Basel, Switzerland)|June 17, 2017
Novel Tacrine-Scutellarin Hybrids as Multipotent Anti-Alzheimer's Agents: Design, Synthesis and Biological EvaluationKatarina Spilovska, Jan Korabecny, Vendula Sepsova, et al.
Molecules (Basel, Switzerland)|August 10, 2017
Development of 2-Methoxyhuprine as Novel Lead for Alzheimer's Disease TherapyEva Mezeiova, Jan Korabecny, Vendula Sepsova, et al.
Pageof 2